ipilimumab,nivolumab
bms
['nadina', 'melanoma']
neoadjuvant thoughts in melanoma #aacr23:
1. radiology undercalls benefit 2. need to see ctdna data 3. t cell clonality to be evaluated 4. no best regimen yet 5. is adjuvant + mrna vaccine = neoadjuvant
6. need randomized-accrue to nadina !!
thoughts 
Chief of Research and Immunotherapy  •  ImmunoOncology  •  Phase I  Clinical Trials  •  Melanoma  •  Cutaneous Oncology